Just north of San Francisco International Airport lies one of the densest clusters of biotechnology companies in the world. The neighborhoods along Brisbane’s and South San Francisco’s eastern ...

A year after a bearish market led to a year-over-year decline in the market capitalization (the product of the share price and the number of outstanding shares) of the top 25 public biotechnology ...

Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned. The San Diego-based company uses biotechnology and artificial ...

Veterans of the biotech business sometimes talk about surviving various “winters” for their industry — periods when funding drops and companies cut jobs or shut down entirely. They’re living through a ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs with high cash burn and no revenue. Biotech IPOs show resilience. Recent market debuts ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s best ...

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector. Biotech stocks lagged the broader market in ...

For 30 years, Pact & Partners has helped life science companies in Europe, Asia, and the Middle East break into markets. But the US? It's the trickiest, yet most important. When foreign biotech and ...

With disruption in our DNA, we are home to today’s top and emerging biotech companies, helping them pioneer a better tomorrow. With its rules-based, transparent index methodology utilizing modified ...